This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The pandemic has ushered in a number of major changes to healthcare systems, notably in the ways in which pharmaceuticalcompanies communicate, visit and engage with physicians. The webinar will also cover: How HCP engagement changed for pharma in 2020. How engagement with HCPs will evolve in the future.
The journey between closing Series A and ‘scale-up’ is one of the hardest, fastest moving company transformation phases – and it requires the most versatile, creative CEOs. In this webinar, we will discuss the challenges CEOs face and their personal journey during this exciting stage of entrepreneurship. Post-Series A challenges.
Pharmaceuticalcompanies often struggle to actively involve patients in the design phase of clinical trials but doing so can have huge benefits for the sustainability and success of research. The webinar will also cover: Building better relationships between pharma/CROs and patient advocates.
That’s the role of the pharmaceuticalcompanies that employ MSLs and their partners who help to design engaging education platforms and curricula in order to best prepare these important communicators. This webinar will also explore: How the changing nature of communications technology and modalities are changing the MSL’s role.
Unlike traditional consumer brands, pharmaceuticalcompanies face unique challenges on social media, including strict regulations, compliance concerns, and the need for factual accuracy. For pharmaceuticalcompanies, this can provide insights into public perception of drug launches, patient experiences, and industry discussions.
Brand Authority: By appearing at the top of search engine results, pharmaceuticalcompanies increase brand credibility among HCPs. Conversion Rate: Tracks how many users complete a desired action, such as signing up for a webinar or downloading whitepapers. Offer incentives like exclusive research reports or webinar invites.
Use medical conferences, webinars, and educational content to connect with HCPs authentically. Healthcare marketing bridges the gap between pharmaceuticalcompanies and their audience, enhancing brand awareness and trust. How can digital marketing benefit pharmaceuticalcompanies? Building trust is vital.
This webinar will also explore: What’s next for digital healthcare communications. Large pharma vs small pharma: differences in digital strategy. Reaching stakeholders through geographical and cultural differences. About the panel.
If there’s one take-home message about working during a pandemic, it is the enormous value that virtual events, webinars and e-learning can bring when face-to-face meetings and presentations are impossible. The main advantage of webinars and other online interactions is pretty obvious.
COVID-19 has brought many changes to the pharmaceutical industry, among them a need to change how pharma companies engage with HCPs and transform their approach to digital channels.
Social media platforms can be a great way for pharmaceuticalcompanies to connect with their target audience and promote their products or services. You can use LinkedIn to share news about your company, post job openings, and connect with potential customers. You can also use YouTube to host webinars and other live events.
Overview Join our live webinar taking place on Tuesday 23rd July at 16:00 BST / 11:00 EST / 08:00 PST. How can pharmaceutical marketers capitalise on this trend and free up budget to invest in additional marketing channels? Customer journeys in pharma are changing, with important implications for the marketing supply chain.
Over recent years, many pharmaceuticalcompanies have taken up environment, social and governance (ESG) targets in order to prioritize sustainability whilst boosting their external public relations. GlobalData is the parent company of Pharmaceutical Technology. Click here to watch the full webinar.
In today’s competitive global market, pharmaceuticalcompanies cannot afford to waste time or resources on strategies that do not fit patient needs or generate scripts. But how do you ensure you are making the right connections and ensuring all key stakeholders have access to tailored education around treatments?
Alongside this, virtual meetings and webinars have been offered to the point of ‘virtual fatigue’ and there has been heavy reliance on email as a means of raising awareness of all these digital activities. We are also witnessing a watershed moment for social media, with both HCPs and pharma using mainstream social platforms in higher volume.
This puts them in a unique position in terms of being able to maximise the benefits that patients get from their medicines – however, healthcare systems and pharmaceuticalcompanies frequently overlook this potential.
Developing strong and meaningful relationships with Healthcare Professionals (HCPs) is vital for healthcare organizations, pharmaceuticalcompanies, and medical device manufacturers alike. Consider organizing workshops, webinars, or conferences to share valuable medical insights, research, and developments.
But how can healthcare systems make this transition – and how do pharmaceuticalcompanies play a role in this, while also growing their market? Across Europe, a shift towards greater prevention, earlier diagnosis and treatment is needed in order to contain the growing cost of healthcare.
This pharmaphorum webinar will take place on 8th April and comes as the COVID-19 outbreak has exposed the challenges pharmaceuticalcompanies face as they race to develop a coronavirus vaccine.
This webinar brings together experts in digital marketing with case studies from a leading pharmaceuticalcompany to keep you up to date with the latest technology and trends and provide practical advice on how to maximize your impact. What are the best ways to choose the right channels and the right content?
This internationally relevant webinar will provide US and European examples to illustrate the ways in which the pharmaceutical market for orphan medicines is changing and how, consequently, launch strategies must evolve.
This pharmaphorum webinar, in association with Ashfield Meetings & Events, will dive into a unique study of HCP educational and behavioural preferences towards attendance at medical congresses. National and international congresses have been identified as the primary event to attend by HCPs.
To meet these challenges, pharmaceuticalcompanies are accelerating digital transformation and making manufacturing more responsive to changing market conditions while improving efficiency. Join the webinar to learn about a new approach to enterprise OT data management. Register Now!
The Guidance applies to all member companies of EFPIA and IFPMA, but also acts as useful guidance for all pharmaceuticalcompanies as to how the authorities will interpret the legislative provisions to social media channels. The Guidance applies to both product-related and therapeutic-area-related activities.
Overview In today’s digital world it is increasingly hard for pharmaceuticalcompanies to successfully differentiate new brands based on their target product profile alone. Instead, the key factor now is often the quality of customer engagement, which more and more healthcare professionals (HCPs) appear to value.
Two-thirds of pharma companies feel well-resourced for digital HCP engagement, with all functions (digital, marketing, commercial and medical) having received increased budget and responsibility specifically for this purpose. It isn’t all doom and gloom, though. For more information visit www.epghealth.com.
Blogs, whitepapers, webinars, and infographics can help position your brand as a trusted authority. Why is digital marketing important for pharmaceuticalcompanies? Content Marketing: Educate, Dont Just Sell Patients and HCPs are constantly searching for medical information.
Pharmaceuticalcompanies spend a huge amount of time and resources on creating valuable brand strategies, but when they come to life there’s often a disconnect.
In a recent webinar held by pharmaphorum, in partnership with IQVIA, a discussion was held looking at how to make academic and commercial medical research more efficient, while also looking at the opportunity of genomic data to bring benefits to patients and healthcare systems.
Another recent change is the timelier release of scientific information; rather than holding on to clinical trial findings until the ‘perfect’ opportunity to present them at a major congress, 2020 increasingly saw pharmaceuticalcompanies make data public in real time. Conclusion.
The ecosystem is complex, the data and the science can be complex, but our communications have to be the opposite,” Amy Hutnik, EVERSANA’s general manager, professional services, said in a recent pharmaphorum webinar. You can watch the webinar in full here. About the panel.
In an era where medicine is rapidly becoming more personalized, why do pharmaceuticalcompanies still struggle to effectively engage with the very individuals they aim to serve? Additionally, the COVID-19 pandemic has intensified public scrutiny of pharmaceuticalcompanies, creating a unique opportunity to build trust with patients.
Pharmaceutical detailing is the most time-tested marketing format in the medical content world. Old-timer sales reps should remember how pharmaceuticalcompanies reckoned face-to-face (F2F) visits with doctors as the most effective approach to achieving their sales targets. What is Pharmaceutical Detailing?
As one of the biggest pharmaceuticalcompanies in the world, GSK is known for its innovation and is at the forefront when it comes to digital transformation. The first step was changing their business model with a focus on building trust and creating transparency.
Through this collaboration, Viseven’s robust digital content management solutions will integrate seamlessly with SpotMe’s comprehensive event platform, enabling life sciences and pharmaceuticalcompanies to hold high-quality events. For us, having a partner who is forward-thinking and aligned with our vision is paramount.
What does this mean for UK pharmaceuticalcompanies that have historically focused on providing medicines and treatments? On one hand there are calls for them to change – going beyond being simply a supplier of products and moving into the role of partner, sharing risk to drive great health outcomes.
NeedyMeds , a non-profit organization known for providing patients with help in finding pharmaceuticalcompany-sponsored prescription assistance programs and other drug savings options, hosted a webinar about drug importation last year called “ Drug Importation: The topic everyone’s talking about.” He replies “U.S.
These technologies enable pharmaceuticalcompanies to analyze vast amounts of data quickly, identify potential drug candidates, and optimize clinical trials, ultimately accelerating the time-to-market for new therapies. Partnerships and collaborations are gaining traction as innovative marketing strategies in the pharma industry.
But the worm was in the fruit, as, even in the US, pharmaceuticalcompanies struggled to transform the market into a consumer good market model. As you can see, becoming truly customer centric is not equivalent to writing it in your values and then doing a few webinars with experts. First, the famous Next Best Action.
Medicaid lowered the cost of drugs reimbursed by state Medicaid agencies by requiring pharmaceuticalcompanies to enter into a rebate agreement with the Secretary of the Department of Health and Human Services (HHS) as a precondition for coverage of their drugs by Medicaid as well as Medicare Part B. Add link to Omnicell's Webinars.
It can work more naturally for webinars or bigger, company meetings, but I’ve found it can present issues for smaller groups, where it’s important for everyone to feel involved and be able to contribute equally. While hybrid working is one thing; hybrid meetings are another. About the author.
A recent pharmaphorum webinar on digital transformation , held in association with P360, explored how COVID has fast-tracked pharma’s long-held ambitions to make wider use of digital technology and streamline its communications with HCPs. Follow him on Twitter or connect with him on LinkedIn.
Key Opinion Leaders play a critical role in the life sciences industry – pharmaceuticalcompanies often engage them during clinical trials and drug commercialization. It’s about finding HCP leaders with the most influence within the pharmaceutical industry. In other words, managed KOLs can be a real game-changer.
Omnicell recently joined other 340B industry experts to get an insider's view of the current state of the 340B program at a recent Scottsdale Institute Webinar. The pharmaceuticalcompany notifies the hospital's drug supplier to resume supplying at a 340B discount. Hospitals and clinics are eligible based on defined criteria.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content